Rivastigmine Tartrate a phenyl carbamate derivative exhibiting cognitive stimulating property. This active ingredient binds reversibly to cholinesterase so that it decreases the breakdown of acetylcholine and enhance the cholinergic function. It is a tartrate salt by reaction of rivastigmine with one equivalent of-tartaric acid. It acts as cholinesterase inhibitor that plays the role of a cholinergic drug, and a neuroprotective agent.
Class of Drugs – A cholinesterase inhibitor
Molecular Formula – C18H28N2O8
Molecular Weight - 400.4 g/mol
Working: This is a cholinesterase inhibitor that inhibits both butyryl cholinesterase and acetylcholinesterase. Rivastigmine Tartrate is believed to acts by inhibiting these cholinesterase enzymes that would otherwise break down the brain neurotransmitter acetylcholine.
Uses: Tis particular active component is indicated to treat confusion associated with Alzheimer's disease and Parkinson's disease. Rivastigmine Tartrate does not cure either of these diseases, but it improves memory, awareness, and the ability to perform daily functions. It actively restores the balance of natural substances like neurotransmitters in the brain.
Popular Brands and Dosages: It is used in the active component in a popular brand medicine as mentioned below:
- Exelon: 1.5 mg, 3 mg, 4.5 mg, and 6 mg
This medication is not recommended to cure Alzheimer's or Parkinson's disease. It should not be given to nursing mothers; it may harm nursing baby.